KR920700220A - 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c - Google Patents
활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질cInfo
- Publication number
- KR920700220A KR920700220A KR1019900702600A KR900702600A KR920700220A KR 920700220 A KR920700220 A KR 920700220A KR 1019900702600 A KR1019900702600 A KR 1019900702600A KR 900702600 A KR900702600 A KR 900702600A KR 920700220 A KR920700220 A KR 920700220A
- Authority
- KR
- South Korea
- Prior art keywords
- active protein
- protein
- aprotinin
- solution
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
내용 없음
Description
내용없음
Claims (10)
- 활성단백질C을 함유하는 출발물질로부터 활성단백질C (APC)을 제조하는 방법에 있어서, APC가 불용성 어프로티닌에 흡수되고 완충염류 용액으로 상기 APC/어프로티닌 복합제를 세척후에 상기 활성단백질C가 산성 용액 또는 카트로픽 에이전트 용액으로 융리하여 수집됨을 특징으로 하는 활성단백질C의 제조방법.
- 청구범위 1항에 있어서, 불용성 어프로티닌에 대한 활성단백질C의 결합이 7-9사이, 좋기로는 8-8.4 사이의 pH에서 수용됨을 특징으로 하는 방법.
- 청구범위 1 또는 2항에 있어서, 활성단백질C이 1-3사이의 pH를 갖는 산성용액으로 용리하여 수집됨을 특징으로 하는 방법.
- 청구범위 1 또는 2항에 있어서, 활성단백질C이 KSCN 또는 NaSCN으로부터 선택된 카오트로픽 에이젠트를 함유하는 용액으로 용리하여 수집되고, 상기 카로트로픽 에이젠트가 투석으로 제거됨을 특징으로 하는 방법.
- 청구범위 1-4항의 어느 한 항에 있어서, 활성단백질C/어프로티닌 복합제의 세척이 8정도의 pH를 갖는 완충염류 용액으로 수행됨을 특징으로 하는 방법.
- 청구범위 1-5항의 어느 한 항에 있어서, 어프로티닌이 겔상태에서 단위 ㎖당 0.5-5mg의 농도에서 매트릭시에 용해되지 않음을 특징으로 하는 방법.
- 청구범위 1-6항의 어느 한 항에 있어서, 상기 APC를 함유하는 출발물질이 활성면역정제 단백질C과, 단백질C의 활성물질로 처리된 PPSB로부터 선택됨을 특징으로 하는 방법.
- 청구범위 1-6항의 어느 한 항에 있어서, 출발물질이 프로트롬빈 복합체의 농축물이고, 단백질C의 칼슘을 첨가하여 상기 출발물질 내에서 생성된 트롬빈으로 활성화되며, 상기 칼슘은 트롬빈에 의하여 단백질C의 활성화를 위해 제거됨을 특징으로 하는 방법.
- 청구범위 8항에 있어서, 칼슘이 10-100mM의 농도로 출발 물질에 첨가됨을 특징으로 하는 방법.
- 청구범위 1-9항의 어느 한 항에 따른 방법으로 제조됨을 특징으로 하는 활성단백질C용액.※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8904814 | 1989-04-12 | ||
FR8904814A FR2645865B1 (fr) | 1989-04-12 | 1989-04-12 | Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue |
FR9002028 | 1990-02-20 | ||
FR909002028A FR2658517B2 (fr) | 1989-04-12 | 1990-02-20 | Preparation de la proteine c activee et solution de proteine c activee ainsi obtenue. |
PCT/FR1990/000258 WO1990012028A1 (fr) | 1989-04-12 | 1990-04-10 | Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue |
Publications (1)
Publication Number | Publication Date |
---|---|
KR920700220A true KR920700220A (ko) | 1992-02-19 |
Family
ID=26227270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900702600A KR920700220A (ko) | 1989-04-12 | 1990-04-10 | 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c |
Country Status (13)
Country | Link |
---|---|
US (1) | US5198534A (ko) |
EP (1) | EP0424498B1 (ko) |
JP (1) | JPH03505531A (ko) |
KR (1) | KR920700220A (ko) |
AT (1) | ATE106893T1 (ko) |
CA (1) | CA2030783A1 (ko) |
DE (1) | DE69009668T2 (ko) |
DK (1) | DK0424498T3 (ko) |
ES (1) | ES2054355T3 (ko) |
FR (1) | FR2658517B2 (ko) |
MA (1) | MA21807A1 (ko) |
PL (1) | PL284757A1 (ko) |
WO (1) | WO1990012028A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT397615B (de) * | 1991-05-14 | 1994-05-25 | Immuno Ag | Arzneimittel enthaltend protein c |
AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
US6867045B1 (en) * | 1994-11-14 | 2005-03-15 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
JP3745805B2 (ja) * | 1995-10-24 | 2006-02-15 | 日本ケミカルリサーチ株式会社 | トロンボモジュリンの精製方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8319538D0 (en) * | 1983-07-20 | 1983-08-24 | Beecham Group Plc | Compounds |
US4849403A (en) * | 1985-05-29 | 1989-07-18 | Pentapharm Ag | Protein C activator, methods of preparation and use thereof |
DE3882411T2 (de) * | 1987-04-17 | 1993-12-16 | Teijin Ltd | Verfahren zur Trennung von aktiviertem menschlichem Protein C. |
-
1990
- 1990-02-20 FR FR909002028A patent/FR2658517B2/fr not_active Expired - Lifetime
- 1990-04-10 CA CA002030783A patent/CA2030783A1/fr not_active Abandoned
- 1990-04-10 EP EP90907093A patent/EP0424498B1/fr not_active Expired - Lifetime
- 1990-04-10 JP JP2506627A patent/JPH03505531A/ja active Pending
- 1990-04-10 ES ES90907093T patent/ES2054355T3/es not_active Expired - Lifetime
- 1990-04-10 KR KR1019900702600A patent/KR920700220A/ko not_active Application Discontinuation
- 1990-04-10 AT AT90907093T patent/ATE106893T1/de not_active IP Right Cessation
- 1990-04-10 DK DK90907093.0T patent/DK0424498T3/da active
- 1990-04-10 DE DE69009668T patent/DE69009668T2/de not_active Expired - Fee Related
- 1990-04-10 WO PCT/FR1990/000258 patent/WO1990012028A1/fr active IP Right Grant
- 1990-04-10 US US07/613,843 patent/US5198534A/en not_active Expired - Fee Related
- 1990-04-12 PL PL28475790A patent/PL284757A1/xx unknown
- 1990-04-12 MA MA22067A patent/MA21807A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ATE106893T1 (de) | 1994-06-15 |
ES2054355T3 (es) | 1994-08-01 |
MA21807A1 (fr) | 1990-12-31 |
EP0424498A1 (fr) | 1991-05-02 |
CA2030783A1 (fr) | 1990-10-13 |
DE69009668D1 (de) | 1994-07-14 |
PL284757A1 (en) | 1991-01-14 |
WO1990012028A1 (fr) | 1990-10-18 |
DE69009668T2 (de) | 1994-10-06 |
DK0424498T3 (da) | 1994-07-04 |
US5198534A (en) | 1993-03-30 |
EP0424498B1 (fr) | 1994-06-08 |
JPH03505531A (ja) | 1991-12-05 |
FR2658517B2 (fr) | 1992-06-19 |
FR2658517A2 (fr) | 1991-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3842061A (en) | Method for isolation of antithrombin from animal tissue materials by adsorption on sulfated carbohydrate gel | |
RU2008130356A (ru) | Удаление плазмин(оген)а из белковых растворов | |
ATE179425T1 (de) | Verfahren zur abreicherung oder entfernung von endotoxinen | |
ES2106742T3 (es) | Procedimiento de purificacion de proteinas. | |
US4303650A (en) | Process for production of erythropoietin | |
EP0230945A3 (en) | Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same | |
EP0041173B2 (en) | Blood-coagulation-promoting products and methods of preparing them | |
US4314994A (en) | Process for obtaining a plasminogen activator | |
ATE95189T1 (de) | Verfahren zur reinigung von annexinen. | |
US4380511A (en) | Purification of bovine thrombin | |
KR920700220A (ko) | 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c | |
KR940027658A (ko) | 트롬빈 결합성 물질 및 이의 제조방법 | |
KR960705921A (ko) | 사람 활성화 단백질 C제제 및 이의 제조 방법(Human activated protein C preparation and process for producing the same) | |
ATE141284T1 (de) | Verfahren zur herstellung von hochreinem fibrinogen | |
RU96110890A (ru) | Способ получения с помощью хроматографических методов вирусно-инактивированной фракции, содержащей фактор viii | |
ES502498A0 (es) | Procedimiento para preparar un complejo de coagulacion san- guinea | |
HUP9901029A2 (hu) | Eljárás rDSPA alfa1 előállítására | |
ATE49420T1 (de) | Verfahren zur reinigung von plasminogenaktivatoren (pa). | |
UA43855C2 (uk) | Спосіб одержання вірусоінактивованої фракції, що містить фактор yiii, та фракція, що містить фактор yiii | |
ES2068270T3 (es) | Procedimiento para la separacion de toxinas a partir de soluciones de proteinas. | |
RU2123860C1 (ru) | Аффинный сорбент для удаления фактора некроза опухоли и способ его получения | |
ES2183050T3 (es) | Estabilizacion selectiva de proteinas por union a un ligando de afin idad inmovilizado durante la inactivacion virica. | |
JPS62181059A (ja) | 体外循環治療用吸着体の前処理方法 | |
JPS6391080A (ja) | ヒト組織プラスミノゲン活性化因子の精製法 | |
JPS6438097A (en) | Method for reactivating protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |